Abstract:As potential antitumor agents, new benzimidazole thiourea derivatives were designed and synthesized. Compounds 7i, 7j, and 7l showed substantial activity against leukemia cell lines in the National Cancer Institute five‐dose assay, with GI50 values ranging from 1.26 to 4.01 μM. Compound 7l, the most active member, inhibited vascular ‎endothelial growth factor receptor 2 (VEGFR‐2) with an IC50 of 63 nM, and triggered apoptosis and cycle arrest in the HL‐60(TB) leukemia cell line. Novel benzimidazole thiourea derivatives were designed and synthesized based on sorafenib as a lead compound. The benzimidazole moiety was traded by the pyridine ring to enhance the hydrophobic interaction and retain hydrogen bonding in the hinge region, while lipophilic moieties with different bulkiness were employed in the deep hydrophobic pocket for better hydrophobic interactions. Thiourea as a urea bioisostere was also utilized. Substantial activity was demonstrated against a leukemia subpanel in an in vitro antitumor screening at the NCI. In the single‐dose assay, compounds 7i, 7j, and 7l had a GI%) higher than sorafenib against most leukemia cell lines (GI% = 86.2%–137.1%), while in the five‐dose assay, compound 7l outperformed sorafenib against the HL‐60(TB) and SR leukemia cell lines in terms of GI50, TGI, and LC50. Compound 7l also caused cycle arrest at the G0–G1 and S phases in the HL‐60(TB) leukemia cell line and induced apoptosis via elevating the Bax/Bcl‐2 ratio and increasing caspases 3, 7, and 9 by 5.1‐, 3.2‐, and 5.2‐fold, respectively. Compounds 7i, 7j, and 7l also inhibited the vascular ‎endothelial growth factor receptor‐2 (VEGFR‐2), B‐Raf(V600E), and platelet‐derived growth factor receptor ‎beta (PDGFR‐β) enzymes with an IC50 range of 0.063–0.44 μM. COMPARE analysis and a molecular docking study were also performed to predict the possible mechanism of action and binding mode, respectively.

Synthesis and structure-activity relationships of N-benzyl-N-(X-2-hydroxybenzyl)-N'-phenylureas and thioureas as antitumor agents.

Design, Synthesis, Anti-Tumor Activity, and Molecular Modeling of Quinazoline and Pyrido[2,3-D]Pyrimidine Derivatives Targeting Epidermal Growth Factor Receptor

Design, modification and 3D QSAR studies of novel naphthalin-containing pyrazoline derivatives with/without thiourea skeleton as anticancer agents.

Synthesis, molecular modeling and biological evaluation of 2-(benzylthio)-5-aryloxadiazole derivatives as anti-tumor agents.

Design, synthesis, biological evaluation and docking study of novel quinazoline derivatives as EGFR-TK inhibitors

Design, Synthesis and Biological Evaluation of N-phenylsulfonylnicotinamide Derivatives As Novel Antitumor Inhibitors.

Design, synthesis, and evaluation of new benzimidazole‏ ‏‎thiourea ‎derivatives as antitumor agents

Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives containing benzodioxole as potential anticancer agents.

Synthesis, Structure and Biological Evaluation of Thiourea Derivatives As Antitumor Agents

Synthesis of Novel 2-((3-(Benzofuran-2-yl)-1-phenyl-1H-pyrazol-4-yl)methylene)hydrazinyl-4-phenylthiazole: Potent EGFR Targeting Anticancer Agents

Design, Synthesis and Antitumor Assessment of Phenylureas Bearing 5-Fluoroindolin-2-one Moiety

Synthesis, anticancer activity and molecular simulation of N-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)thioureas containing pyrimidine ring

Synthesis, Biological Evaluation and Molecular Docking Studies of Amide-Coupled Benzoic Nitrogen Mustard Derivatives As Potential Antitumor Agents.

Rational synthesis and evaluation of 2,4-diamino-thieno[2,3-d]pyrimidines as antitumor agents

Novel quinazolines bearing 1,3,4-thiadiazole-aryl urea derivative as anticancer agents: design, synthesis, molecular docking, DFT and bioactivity evaluations

Synthesis and Biological Evaluation of 2-(6-Phenylimidazo[2,1-b][1,3,4]thiadiazol-2-yl)benzo[d]thiazole Derivatives as EGFR Targeting Anticancer Agents

Efficient synthesis and cytotoxic activity of polysubstituted thieno[2,3-d]pyrimidine derivatives

Synthesis and Biological Evaluation of Compounds Which Contain Pyrazole, Thiazole and Naphthalene Ring As Antitumor Agents.

Design and Synthesis of Thiourea Derivatives Containing a Benzo[5,6]cyclohepta[1,2-B]pyridine Moiety As Potential Antitumor and Anti-Inflammatory Agents.

Identification of novel ureido benzothiophenes as dual VEGFR-2/EGFR anticancer agents

Synthesis and Anti-tumor Activity of Novel 2-Amino-1,3,4-thiadiazole Derivativers